Multiplex detection of antibodies to Chikungunya, O'nyong-nyong, Zika, Dengue, West Nile and Usutu viruses in diverse non-human primate species from Cameroon and the Democratic Republic of Congo by Raulino, Raisa et al.
RESEARCH ARTICLE
Multiplex detection of antibodies to
Chikungunya, O’nyong-nyong, Zika, Dengue,
West Nile and Usutu viruses in diverse non-
human primate species from Cameroon and
the Democratic Republic of Congo
Raisa Raulino1, Guillaume Thaurignac1, Christelle Butel1, Christian Julian Villabona-
ArenasID
1, Thomas Foe1, Severin Loul2, Simon-Pierre Ndimbo-Kumugo3, Placide Mbala-
Kingebeni3, Sheila Makiala-MandandaID
3, Steve Ahuka-Mundeke3, Karen Kerkhof4,
Eric DelaporteID
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pour le Développement et Université de Montpellier, France, 2 Centre de Recherches sur les Maladies
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Epidemic arbovirus transmission occurs among humans by mosquito bites and the sylvatic
transmission cycles involving non-human primates (NHPs) still exists. However, limited data
are available on the extent in NHPs infections and their role. In this study, we have devel-
oped and validated a high-throughput serological screening tool to study the circulation of
multiple arboviruses that represent a significant threat to human health, in NHPs in Central
Africa.
Methodology/Principal findings
Recombinant proteins NS1, envelope domain-3 (DIII) for the dengue (DENV), yellow fever
(YFV), usutu (USUV), west nile (WNV) and zika (ZIKV) and envelope 2 for the chikungunya
(CHIKV) and o’nyong-nyong (ONNV) were coupled to Luminex beads to detect IgG directed
against these viruses. Evaluation of test performance was made using 161 human sera of
known arboviral status (66 negative and 95 positive). The sensitivity and specificity of each
antigen were determined by statistical methods and ROC curves (except for ONNV and
USUV). All NS1 antigens (except NS1-YFV), CHIKV-E2 and WNV-DIII had sensitivities and
specificities > 95%. For the other DIII antigens, the sensitivity was low, limiting the interest of
their use for seroprevalence studies. Few simultaneous reactions were observed between
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the CHIKV+ samples and the NS1 antigens to the non-CHIKV arboviruses. On the other
hand, the DENV+ samples crossed-reacted with NS1 of all the DENV serotypes (1 to 4), as
well as with ZIKV, USUV and to a lesser extent with YFV. A total of 3,518 samples of 29 spe-
cies of NHPs from Cameroon and the Democratic Republic of Congo (DRC) were tested
against NS1 (except YFV), E2 (CHIKV/ONNV) and DIII (WNV) antigens. In monkeys (n =
2,100), the global prevalence varied between 2 and 5% for the ten antigens tested. When
we stratified by monkey’s biotope, the arboreal species showed the highest reactivity. In
monkeys from Cameroon, the highest IgG prevalence were observed against ONNV-E2
and DENV2-NS1 with 3.95% and 3.40% respectively and in DRC, ONNV-E2 (6.63%) and
WNV-NS1 (4.42%). Overall prevalence was low in apes (n = 1,418): ranging from 0% for
USUV-NS1 to 2.6% for CHIKV-E2. However, a very large disparity was observed among
collection site and ape species, e.g. 18% (9/40) and 8.2% (4/49) of gorillas were reactive
with CHIKV-E2 or WNV-NS1, respectively in two different sites in Cameroon.
Conclusions/Significance
We have developed a serological assay based on Luminex technology, with high specificity
and sensitivity for simultaneous detection of antibodies to 10 antigens from 6 different arbo-
viruses. This is the first study that evaluated on a large scale the presence of antibodies to
arboviruses in NHPs to evaluate their role in sylvatic cycles. The overall low prevalence
(<5%) in more than 3,500 NHPs samples from Cameroon and the DRC does not allow us to
affirm that NHP are reservoirs, but rather, intermediate hosts of these viruses.
Author summary
In the last decades, chikungunya, zika, yellow fever, usutu and dengue viruses have (re)-
emerged in different parts of the world and many of these outbreaks occur in resource-
limited countries with limited or under-equipped health facilities and where endemic
malaria with very similar clinical symptoms confounds surveillance. Most arboviruses
that circulate today likely originated in Africa where sporadic human outbreaks occur. In
this work, we developed a serological tool that allows simultaneous detection of IgG anti-
bodies to multiple arbovirus in a biological sample. With this highly sensitive and specific
multiplex assay, we screened more than 3,500 samples collected from 29 species of mon-
keys and apes in Africa. We found a global IgG antibody prevalence of less than 5%. How-
ever, this seroprevalence varied by collection site, NPHs species and virus type. Given
these findings, we concluded that African non-human primates are most likely not the
reservoirs, but rather are intermediate hosts.
Introduction
Ecology and human behavior play a major role in the increasing emergence and re-emergence
of infectious diseases and several factors are required for this to occur [1]. These include preva-
lence of pathogens in the natural host, transmission mode of the pathogens, frequent contact
between humans and wildlife, capacity to adapt to a new host and conditions for subsequent
epidemic spread into the human population [2,3]. In particular, the increased contact between
humans and wildlife lead to increased risk for disease emergence in humans [4,5].
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In the last decades, chikungunya (CHIKV), zika (ZIKV), yellow fever (YFV), usutu
(USUV) and dengue (DENV) viruses have (re)-emerged in different parts of the world [6–8],
many of these outbreaks occur in resource-limited countries with limited or under-equipped
health facilities and where endemic malaria with very similar clinical symptoms confounds
surveillance [9]. Most arboviruses that circulate today likely originated in Africa where spo-
radic human outbreaks occur: YFV is known to circulate endemically in Sub-Saharan Africa
for centuries [10]; west nile virus (WNV) and ZIKV were first identified in 1937 and 1947,
respectively, in Uganda [11]; CHIKV in 1952 in Tanzania [12] USUV in 1959 in South Africa.
The precise origins of DENV remain unknown but it is widely prevalent in East, Central and
South Africa.
While large outbreaks of arbovirus diseases in human populations are well documented
[13–15], many questions remain unanswered on their sylvatic-cycles, in particular, which
wildlife species could be involved. In almost any review or research article, the zoonotic cycles
for ZIKV, DENV, YFV CHIKV are presented with arboreal mosquitos feeding on non-human
primates (NHPs) but this is based on very limited data. There is only very limited evidence of
arbovirus infection or exposure in NHPs but also in wildlife in general. Studying the animal
reservoir of arboviruses is a challenging question, because (i) there are difficulties inherent in
wildlife sampling, (ii) there are limited high throughput screening technologies, (iii) the anti-
genic proximity among arboviruses hinders specificity and (iv) arboviruses cause acute infec-
tions which limits the detection of the virus to a very narrow window of time, rarely exceeding
3 weeks [16]. The detection of antibodies against arboviruses antigens represent an alternative
to virus detection but information on seroprevalence in wildlife are very limited. A few studies
reported prevalence of antibodies (mostly IgG) in different African non-human primates
(NHPs) species (reviewed in Valentine and colleagues in 2019) [17], which varied from 0% to
100%, depending on the species, the targeted arbovirus, the detection method used, the coun-
try of sample’s origin and the number of samples tested.
In the present work, we have addressed some of these challenges. We first developed a high
throughput serological screening tool based on the Luminex technology. Next, we screened
more than 3,500 samples of a wide diversity of NHPs species from Cameroon and the Demo-
cratic Republic of Congo (DRC) for presence of antibodies to multiple arboviruses in order to
evaluate their potential role in sylvatic cycles. Our data show an overall low seroprevalence of
IgG antibodies to arboviruses unevenly distributed according to NHPs species and to sample
collection site.
Materials and methods
Human panel samples and ethics statement
We used a panel of 161 samples of known arbovirus serostatus to validate our Luminex based
serological test (S1 Table). All the human samples used in this study were anonymized, and
there is no way to link back these leftovers to the 161 patients. The panel consisted of 66 arbo-
virus negative leftover plasma samples from the Virology department of the University Hospi-
tal, Montpellier, France and the Institute of Tropical Medicine, Antwerp, Belgium. The
patients were referred to these laboratories for various illnesses and were tested for the pres-
ence of an arboviral infection by IgM and IgG Immunofluorescence assay or ELISA assays,
PCR and sero-neutralization for some of them. All 66 negative control samples used in the
present study were negative with all these assays. Positive control samples for CHIKV, DENV,
WNV, YFV and ZIKV originated from patients in France, Belgium, Colombia and the DRC.
The samples were obtained as follows: during outbreaks (CHIKV and YFV in the DRC,
DENV in Colombia and WNV in France); returning travelers in Europe from countries with
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outbreaks (ZIKV, DENV) or vaccinees (YFV in Colombia). DENV positive sera consisted of
six DENV-1, seven DENV-2, four DENV-3, three DENV-4 and three DENV-1,2,3,4 reactive
samples. Outbreak and returning travelers’ samples were confirmed positive by PCR and fol-
low-up serum samples, confirmed by commercial serological assays, were used in the present
study. For USUV, we had only three samples from experimentally infected mice that were seri-
ally bleeded. We were not able to get positive controls for o’nyong nyong virus (ONNV).
Samples from monkeys and apes
We tested samples from bushmeat and pet monkeys from studies that were conducted between
1999 and 2016 on simian retroviruses and the origin of HIV [18–20] in 14 different sites in
southern Cameroon and the DRC (Fig 1 and S2A Table). Whole blood was collected from
monkey bushmeat, either by intracardiac puncture and subsequent storage at –20˚C, or as a
dried blood spot (DBS) on Whatman 903 filter paper (GE Healthcare) at the points of hunting
injury and spotting, as described previously [21]. Blood was drawn on EDTA tubes from pet
monkeys by venipuncture after tranquilization with ketamine [20]. Species were visually iden-
tified in the field and confirmed on a subset of samples by 12S sequence analysis, as previously
described [22]. Fecal samples were collected between 2005 and 2017 from wild common chim-
panzees (Pan troglodytes troglodytes), western lowland gorillas (Gorilla gorilla gorilla), eastern
lowland gorillas (Gorilla beringei graueri) and bonobos (Pan paniscus) at 18 different sites in
Cameroon and DRC as part of studies on the origin of HIV [23] (Fig 1 and S2B Table). Feces
were stored in RNA-later (Sigma-Aldrich, Saint-Quentin Fallavier, France), kept at ambient
temperature in the field for a maximum of three weeks, and then stored at –20˚C or –80˚C in
central repository laboratory.
Screening for IgG antibodies to arboviruses
Recombinant proteins. We used different commercially available recombinant proteins
derived from the envelope or non-structural proteins of CHIKV, ONNV, DENV, ZIKV,
USUV, YFV and WNV viruses (S3 Table). The proteins were purchased already purified (all
Fig 1. Sample collection sites. Sites where samples from non-human primates (NHPs) were collected are highlighted
with circles on the maps, as follows: blue indicates sites where bushmeat samples from monkeys were collected; red,
sites where fecal samples from apes were collected; blue and red, sites where bushmeat samples from monkeys and
fecal samples from apes were collected. Abbreviations of sites are as follows: BP, Bipindi; BQ, north of Dja; EB,
Eboumetoum; EW, Ebolowa; GM, Goma; KL, Kole; MBk, Mbandaka; MK, Monkoto; ML, Malebo; MN, Mindourou;
MS, Messok; ND, Nditam; WK, Walikale; YD, Yaoundé.
https://doi.org/10.1371/journal.pntd.0009028.g001
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above 95% of purity, except DENV4_NS1 and CHIKV_NSP at>90%) as lyophilized powders,
and resuspended in a buffer at concentration as per manufacturer’s instructions, aliquoted and
stored frozen at -20˚C until use.
Protein coupling to Luminex beads. We used our previously described protocol for cou-
pling primary amines bearing moieties (peptides and proteins) to Luminex beads [21,24].
Briefly, recombinant proteins (1–4μg/1.25 x106 beads) were covalently coupled on carboxyl
functionalized fluorescent magnetic beads (Luminex Corp., Austin, TX) with the BioPlex
amine coupling kit (Bio-Rad Laboratories, Marnes-la-Coquette, France) according to the man-
ufacturer’s instructions. We blocked unreacted sites with blocking buffer from the amine cou-
pling kit. Protein-coupled microsphere preparations were washed with PBS, and stored in
storage buffer (Bio-Rad) at 4˚C in the dark until use.
Multiplex screening for IgG antibodies to arbovirus in plasma and fecal dialysates.
Before use, recombinant protein-coupled beads were vortexed for 30s and diluted to 2,000
beads/μl of assay buffer (Phosphate Buffered Saline (PBS) containing 0.75 mol/L NaCl, 1%
(wt/vol) bovine serum albumin (Sigma Aldrich, Saint-Quentin Fallavier, France), 5% (vol/vol)
heat-inactivated fetal bovine serum (Gibco-Invitrogen, Cergy Pontoise, France), and 0.2%
(vol/vol) Tween-20 (Sigma-Aldrich). Tests were performed in 96-well flat-bottom chimney
plates (Greiner bio one, Frickenhausen, Germany). Fifty microliters of bead mixture were
added to each well. Preliminary experiments on different plasma dilutions (1/50-1/1,000) and
different incubation times and temperatures showed that the dilution 1/200 and +4˚C over-
night incubation gave the best signal to noise ratio. Liquid was aspirated with an automatic
plate washer (BioTek 405TS Microplate washer) and wells were then incubated with 100 μl of
plasma (diluted 1/200 in assay buffer) for 16h at 4˚C in the dark on a plate shaker at 300 rpm/
min. After 3 washings with 100 μl of assay buffer, 50 μl of biotin-labeled anti-human IgG was
added (BD-Pharmingen, Le Pont De Claix, France) at a concentration of 4 μg/ml in each well
and incubated for 30 min in the dark while shaking at 300 rpm. Plates were washed 3 times as
above, and 50 μl of streptavidin-R-phycoerythrin (Fisher Scientific/Life Technologies, Illkirch,
France) at 1 μg/ml were added per well and incubated for ten min with shaking at 300 rpm. As
in previous studies from our group and others, anti-human IgG was also used for NHPs
[21,25]. Antigen-antibody reactions were then read on BioPlex-200 equipment (Bio-Rad,
Marnes-la-Coquette. France). At least 100 events were read for each bead set, and the results
were expressed as median fluorescence intensity (MFI) per 100 beads. To detect IgG antibodies
to arboviruses in fecal samples, RNA-later-precipitated immunoglobulins were first resolubi-
lized by diluting the fecal/RNA-later mixture (2 mL) with PBS–0.05% Tween 20 (7 mL), fol-
lowed by incubation for 1 hour at 60˚C, centrifugation (3900g for 10 minutes) to clarify the
solution, and dialysis against PBS overnight at 4˚C under a continuous stirring. The reconsti-
tuted extracts were then tested in the Luminex (diluted three volumes of dialysate for one vol-
ume of buffer) as previously described [24].
Calculation of cut-off, sensitivity, specificity and accuracy. For the samples of the panel,
we used receiver operating characteristics (ROC) curve analysis to determine the cut-off values
for each antigen, its sensitivity, specificity and accuracy which corresponds to the area under
the curve (AUC). The ROC curve analysis was performed with the Life module of XLSTAT
(Addinsoft, Paris, France) implemented in Microsoft Excel. We also determined the sensitiv-
ity, specificity and accuracy by calculating the mean MFI of negative controls for each antigen,
the standard deviation to the mean (SD) and using as cut-off the mean plus three times the SD
because for ONNV and USUV, no or only limited positive control samples were available. We
used the Wilson method [26] to calculate online the 95% confidence intervals (CI) around the
proportions (http://ww3.ac-poitiers.fr/math/prof/resso/cali/ic_phrek.html).
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In the absence of positive controls for NHPs samples, we analyzed the data obtained from
plasma and DBS samples with different statistical methods to determine MFI cut-off values for
each antigen as reported in our previous studies on ebolavirus in NHPs [27]. We used a
change-point analysis with the R package “changepoint” and calculated one single shift in the
arithmetic mean with the AMOC (at most one change) method. We also fitted univariate dis-
tributions to our data and defined the cut-off based on a 0.05 risk of error [28]. The set of can-
didate distributions was reduced with a bootstrapped skewness-kurtosis analysis [29].
Maximum likelihood estimation was performed to select the best-fit distribution based on
AIC (Akaike information criterion) using the R library “fitdistrplus” [30]. The best-fit distribu-
tions were negative binomial and negative exponential distributions and both were considered
in data analyses. Data were bootstrapped 10,000 times and averaged for each antigen. Analyses
were done with R software version 3.3.6. We then compared the cut-off values identified by
the 3 different methods and calculated their mean as a consensus cut-off that we used in this
study (S4 Table). We calculated separately cut-off values for samples collected as DBS (samples
from the DRC) and those collected as blood in EDTA tubes (samples from Cameroon) because
of the wide disparity of blood quantity collected with DBS. We considered a sample antigen
reactive if MFI was above the cut-off value. Likewise, for samples collected as feces, we calcu-
late MFI cut-off values separately on the data generate from the dialysates (S5 Table). We con-
sidered samples positive for a given antigen if they presented MFI above the cut-off value for
this antigen.
Results
Performance of the arbovirus Luminex assay on a reference panel of human
samples
Before proceeding to the screening of NHPs samples, we first evaluated the performance of the
novel Luminex-based serological assay on the panel of human samples with known status (S1
Table). To determine the assay performances, we first calculated cut-off values by two meth-
ods for 15 of the 17 antigens included. For USUV and ONNV, it was not possible to use ROC
analysis because of the absence of positive controls and cut-off values were determined as
3XSD of negative samples. Results of cut-off determinations are summarized in Table 1.
Regardless of the cut-off method used to determine the sensitivity, specificity and accuracy of
each antigen, the specificity is in general high,> 95%, for the majority of the antigens. The sen-
sitivity, on the contrary, depended on the virus and on the recombinant protein used. The sen-
sitivity of NS1 recombinant proteins as determined by the ROC analysis method was 100% for
WNV, DENV-2, DENV-3, ZIKV and>95% for DENV-1; 87% for DENV-4 and only 44% for
YFV proteins. We also observed a 100% sensitivity for WNV-DIII protein. Sensitivity of
CHIKV-E2 envelope protein was also high,>95% by ROC analysis. Of note, DIII recombinant
proteins from the envelope, except WNV-DIII, presented weaker sensitivity, compared to NS1
recombinant proteins.
One hallmark of sero-detection of antibodies to arboviruses is cross-reaction due to anti-
genic homology between the different viruses. For the evaluation of the level of cross-reaction
on our panel of 95 positive samples, we used cutoff values obtained with the ROC analysis
method (except for ONNV and USUV). S6 Table shows the proportion of CHIKV, ZIKV,
DENV, WNV and YFV positive samples that also react present with heterologous antigens. By
doing so, 14/27 (52%) CHIKV+ positive samples cross-reacted with closely related ONNV-E2,
and also with others flavivirus, varying from 2/27 (7.4%) to 16/27 (60%). On the other hand,
flavivirus positive samples presented no or weak cross-reactions with antigens from the alpha-
viruses, CHIKV and ONNV, and variable rates of cross-reactions were observed among the
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ONNV_E2 Mean+3SD 362 66/64 96.97 0.91–
99.0
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different flaviviruses. Unsurprisingly, DENV+ positive samples highly cross-reacted with all
DENV-NS1 proteins, regardless the dengue virus serotype not allowing to differentiate among
dengue serotypes. Cross reactivity was also seen between the DIII proteins of the dengue sero-
types; for example, of the six DENV-1+ samples, five reacted with DENV-1, DENV-3 and
DENV-4 DIII and only DENV-2 DIII antigen presented no reaction with the six DENV-1 pos-
itive samples. DENV+ samples also reacted at high proportion with NS1 antigens from ZIKV
(14/23, 60%), YFV (19/23, 82.6%) and WNV (9/23, 39%). All WNV+ samples cross-reacted
with NS1 antigens from USUV and at different levels (0–36%) with other arboviral antigens.
Finally, YFV+ samples cross-reacted with other NS1 antigens at levels equal or superior to that
of cognate YFV NS1 antigen. To summarize, cross-reactions in our control panel with the dif-
ferent arbovirus antigens is variable and ranged between 0% and 60%.
Overall, accuracy of the different antigens evaluated was excellent (>95%) for all NS1,
except YFV-NS1. CHIKV-E2 and WNV-DIII recombinant proteins also presented high accu-
racy. We thus decided to use only antigens with high sensitivity and specificity (i.e.
CHIKV-E2, ONNV, ZIKV-NS1, DENV1-4-NS1, WNV-NS1 and DIII, USUV-NS1) for the
screening of wildlife samples.
Seroprevalence of IgG antibodies to arboviruses in multiple monkey
species from Cameroon and the DRC
Overall, 2,100 samples collected from 26 different monkey species were screened (S2A Table
and S1 Data). Total IgG antibodies to the ten selected recombinant proteins varied between
2% to 5% (Table 2). We analyzed more in detail the seroprevalence of IgG antibodies to the
different arbovirus antigens, stratifying by monkey species (Table 2). Seven of 26 species
screened were IgG negative towards all the antigens tested, i.e. red-capped mangabey (n = 7),
Hamlyn’s monkey (n = 6), L’Hoest’s monkey (n = 38), Preuss’s monkey (n = 1), drill (n = 1),
mandrills (n = 24) and olive baboon (n = 16). It should be noted that for four of these seven





























USUV_NS1 Mean+3SD 89 66/65 98.48 91.0–
99.0
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(CHIKV: Chikungunya virus); (ZIKV: Zika virus); (DENV: Dengue virus); (USUV: Usutu virus); (WNV: West Nile virus); (YFV: Yellow Fever virus); (ONNV:
O’Nyong Nyong virus).
a MFI: median fluorescence intensity
b CI: confidence interval.
https://doi.org/10.1371/journal.pntd.0009028.t001
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Table 2. Seroprevalence of IgG antibodies to Chikungunya (CHIKV), O’nyong nyong (ONNV), Zika (ZIKV), Dengue (DENV), Usutu (USUV) and West Nile
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Preuss monkey 1 - - - - - - - - - - - (0.0–
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Olive baboon 16 - - - - - - - - - - - (0.0–
0.0)
(Continued)
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IgG reaction against at least one antigen, seroprevalence varied greatly by monkey species and
virus antigen. Hence, the blue monkey presented the highest proportion of positive samples, 31%
(16/51), against CHIKV and were only marginally positive (1/51) against ZIKV and DENV-3 NS1
recombinant proteins. The next monkey species presenting high proportions of reactive samples
are black colobus with 28% (2/7) reactive against CHIKV-E2 and DENV-NS1 recombinant pro-
teins, angolan colobus and northern talapoin with 8% (2/25) and 11% (2/18) reactive samples
against DENV-NS1 and WNV-DIII antigens, respectively. Red-tailed and mona monkeys pre-
sented 12% (23/181) and 11% (1/9) reactive samples against ONNV_E2 antigen. The remaining
13 monkey species presented less than 8% of reactive samples against any of the tested antigens.
Thereafter, IgG antibodies were stratified by collection sites and prevalences showed varia-
tion between 1.46% (WNV_NS1 in Cameroon) and 6.63% (ONNV_E2 in the DRC) (Table 3).
The proportions of ZIKV and DENV positive samples were in general higher in samples col-
lected in Cameroon than in DRC, while IgG antibodies against CHIKV, ONNV, USUV and
WNV antigens were higher in samples collected in DRC than in Cameroon (Table 3). For
DENV-2 and WNV, the difference was statistically significant (p = 0.0321 for DENV-2, 0.0007
and 0.0039 for WNV-NS1 and WNV-DIII, respectively). The proportion of positive samples is
also unevenly distributed among the sampling sites within countries. A clear difference was
observed between samples collected from pets and those obtained from feral monkeys. Hence
8/175 (4.5%) samples from pets, all from infant or juvenile monkeys living in urban areas,
reacted with at least one of the antigens, while 5.2–46.6% of samples reacted with at least one
antigen in samples collected from feral monkeys (>90% adults). IgG antibodies to CHIKV-E2
protein were detected at high proportion (35%) in WK, eastern DRC and in lesser extent, in
GM also in eastern DRC and in EB, EW and BP in Cameroon.
We then stratified the proportion of positive samples by NHP biotopes and split NHPs into
three groups: arboreal (n = 1,749), terrestrial (n = 264) and semi-terrestrial (n = 87) species
(Fig 2 and S7 Table). Following this grouping, in the arboreal group positive samples were
detected against all the ten antigens tested. Another remarkable observation is the quasi-
absence of DENV positive samples in semi-terrestrial monkeys, with the exception of one sam-
ple (1/87) with antibodies against DENV-4 NS1 antigen. Finally, in this group of semi-terres-
trial NHPs, despite the relative low number of samples tested (n = 87), high proportions of
reactive samples were observed against WNV and USUV virus antigens.
We also checked for simultaneous reactions to multiple viruses (Table 4). For example, in
Cameroon, 10% of CHIKV-E2 positive samples (n = 40), were also reactive with ONNV-E2,
ZIKV-NS1 and DENV-2 NS1 antigens; 40% of USUV NS1 reactive samples (n = 22) reacted
also with WNV NS1 antigen. In DRC, 18% of CHIKV-E2 reactive samples (n = 27) were reac-
tive with ONNV-E2 and 11% with ZIKV-NS1 antigens. In both countries, DENV-NS1 reactive
samples reacted with other NS1 antigens in proportions ranging between 27 and 63%. Among
















































a -: no positive samples detected
b n/N tested (percentages)
c: nt, not tested.
�The total of samples tested on ONNV, Usutu and WNV antigens are different to those tested on the other antigens for certain species.
https://doi.org/10.1371/journal.pntd.0009028.t002
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Low seroprevalence of IgG antibodies to arboviruses antigens in apes from
Cameroon and the DRC
African apes, including gorillas, chimpanzees and bonobos are endangered species and are on
the red list of IUCN. Thus, only non-invasive sampling methods are allowed as alternative
Fig 2. Proportions of positive samples to several arboviruses and stratified by monkey biotope/habitat. The figure shows the proportion (vertical
axis) of samples positive to the different antigens reported in the horizontal axis, in the different monkey species biotopes as detailed in supplementary
S7 Table.
https://doi.org/10.1371/journal.pntd.0009028.g002
Table 4. Percentages of monkey samples reacting simultaneously with different arboviral recombinant proteins.
Cameroon Number of reactive
samples
ONNV_E2 ZIKV_NS1 DENV1_NS1 DENV2_NS1 DENV3_NS1 DENV4_NS1 USUV_NS1 WNV_NS1 WNV_DIII
CHIKV_E2 40 10.0 10.0 2.5 10.0 2.5 2.5 2.5 2.5 2.5
ONNV_E2 26 7.7 3.8 3.8 3.8 3.8 7.7 7.7 7.7
ZIKV_NS1 47 27.7 36.2 31.9 27.7 29.8 12.8 2.1
DENV1_NS1 26 69.2 50.0 80.8 23.1 19.2 3.8
DENV2_NS1 39 41.0 41.0 17.9 10.3 2.6
DENV3_NS1 22 50.0 22.7 22.7 0.0
DENV4_NS1 37 21.6 16.2 2.7
USUV_NS1 22 40.9 0.0
WNV_NS1 10 0.0
WNV_DIII 15
DRC Number of reactive
samples
ONNV_E2 ZIKV_NS1 DENV1_NS1 DENV2_NS1 DENV3_NS1 DENV4_NS1 USUV_NS1 WNV_NS1 WNV_DIII
CHIKV_E2 27 18.5 11.1 3.7 3.7 3.7 3.7 3.7 3.7 0.0
ONNV_E2 30 13.3 6.7 10.0 3.3 10.0 13.3 16.7 23.3
ZIKV_NS1 18 22.2 16.7 27.8 27.8 33.3 33.3 11.1
DENV1_NS1 11 54.5 63.6 63.6 36.4 27.3 9.1
DENV2_NS1 10 50.0 50.0 40.0 40.0 20.0
DENV3_NS1 12 50.0 41.7 41.7 8.3
DENV4_NS1 13 30.8 30.8 7.7
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methods to study pathogens in these animals. Here we tested dialysates of 1,418 fecal samples
from bonobos, chimpanzees and gorillas on the same antigens used for samples from monkeys
(S1 Data). Overall, the proportions of IgG positive samples against any given arbovirus antigen
was low (<5%) (Table 5). Gorillas, with 4.35% (35/803) reactive samples against CHIKV-E2
antigen, presented the highest proportion of IgG positive samples. There was no DENV posi-
tive sample in the 263 chimpanzees’ fecal dialysates tested. Many samples collected in the
remaining 12 collection sites presented IgG antibodies against multiples arboviral antigens.
For example, samples collected from gorillas in SO (Cameroon) reacted against all the ten anti-
gens. As for monkeys, simultaneous reactions to multiple virus antigens were also observed
with samples from apes. For example, 59%, 19% and 24% of CHIKV-E2 positive samples
reacted also with ONNV-E2, ZIKV-NS1 and WNV-DIII antigens, respectively (Table 6).
Table 5. Seroprevalence of IgG antibodies to Chikungunya (CHIKV), Zika (ZIKV), Dengue (DENV), Usutu (USUV) , O’Nyong nyong (ONNV) and West Nile
(WNV) viruses stratified by ape species and collection site as shown in Fig 1.
Country Sampling site CHIKV ONNV ZIKV DV1 DV2 DV3 DV4 USUV WNV WNV
E2 E2 NS1 NS1 NS1 NS1 NS1 NS1 NS1 DIII
Bonobo
DRCa LP (n = 14) - b - - - 1 (7.14) c - - - 2 (14.2) -
DRC ML (n = 18) - - 1 (5.55) - - - - - - -
DRC MZ (n = 183) 1 (0.54) - - - - - - - - -
DRC LA (n = 137) - - - - 3 (2.1) - 2 (1.4) - 12 (8.75) -
Subtotal n = 352 1 (0.28) - 1 (0.28) - 4 (1.13) - 2 (0.56) - 14 (3.97) -
Chimpanzee
CMR EK (n = 35) - 2 (5.71) 1 (2.85) - - - - - - -
CMR BQ (n = 29) - 2 (6.89) 2 (6.9) - - - - - 2 (6.89) -
CMR CP (n = 5) - - - - - - - - - -
CMR MB (n = 113) 1 (0.88) - - - - - - - 1 (0.88) -
DRC BB (n = 10) - - - - - - - - 2 (20.0) -
DRC LS (n = 71) - - - - - - - - - -
Subtotal n = 263 1 (0.38) 4 (1.52) 3 (1.14) - - - - - 5 (1.90) -
Gorilla
DRC IB (n = 47) - - - - - - - - 2 (4.25) -
CMR EK (n = 65) - - - - - - - - - -
CMR BQ (n = 127) 9 (7.08) 7 (5.51) 10 (7.8) - - - 1 (0.78) - - 3 (2.36)
CMR SO (n = 49) 3 (6.12) 2 (4.08) 2 (4.08) 2 (4.08) 2 (4.08) 2 (4.08) 2 (4.08) 1 (2.04) 4 (8.16) 2 (4.08)
CMR BP (n = 85) - - - - - - - - - -
CMR CP (n = 195) 6 (3.07) 3 (1.53) 2 (1.02) 1 (0.51) 1 (0.51) - - - - 1 (0.51)
CMR MS (n = 48) - 1 (2.08) 2 (4.16) - - - - - - -
CMR DJ (n = 104) 6 (5.76) 2 (1.92) - - - - - - - -
CMR MT (n = 40) 9 (18.3) 7 (17.5) 2 (5.00) - - - - - - 3 (7.5)
CMR LB (n = 20) - - - - - - - - - -
CMR MB (n = 23) 2 (8.69) 1 (4.34) 1 (4.34) - - - - - - -
Subtotal n = 803 35 (4.35) 23 (2.82) 19 (2.36) 3 (0.37) 3 (0.37) 2 (0.25) 3 (0.37) 1 (0.12) 6 (0.74) 9 (1.12)
Total n = 1418 37 (2.60) 27 (1.90) 23 (1.62) 3 (0.21) 7 (0.49) 2 (0.14) 5 (0.35) 1 (0.07) 25 (1.76) 9 (0.63)
a CMR, Cameroon; DRC, Democratic Republic of Congo
b no positive samples were identified
c number of positives (percentages)
https://doi.org/10.1371/journal.pntd.0009028.t005
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Likewise, DENV-1 NS1 reactive samples reacted with 33%-100% of other DENV, WNV and
USUV NS1 antigens.
Discussion
In this study, we used a novel high throughput multiplex immunoassay that included ten anti-
gens derived from six different arboviruses, including the four Dengue serotypes, to evaluate
prevalence of IgG antibodies to these viruses in a large number of samples from NHPs species
from Cameroon and the DRC. Overall, we showed that IgG antibodies to arboviral antigens
are low and unevenly distributed in a wide diversity of the different NHPs species and in the
different sites of the two countries where the samples were collected.
Validation of a serological screening tool
First, we developed a screening tool to detect IgG antibodies to CHIKV, ONNV, DENV,
ZIKV, USUV, YFV and WNV viruses using 17 purified recombinant viral proteins. After per-
formance evaluation, we kept only ten of these antigens for the screening of wildlife samples
that presented the highest sensitivities and/or with high specificities (Table 3). In our assay, we
found that the commonly used NS1 (DENV1-4, ZIKV, WNV) and E2 (CHIKV) antigens
together with WNV-DIII recombinant proteins are the most sensitive antigens to detect IgG
antibodies in our panel, with sensitivity and specificity�95% (Table 1). DIII antigens from
ZIKV and DENV1-4 viruses and NSP for CHIKV were excluded because of low sensitivities.
This could be explained by several parameters, including antibody kinetics, specificity
restricted to one or two epitopes or recombinant protein structure impairment due to in vitro
production issues. YFV-NS1 was not further used because of its low sensitivity, however it can-
not be excluded that positive controls from vaccinated people (15/18) are not the most appro-
priate controls for assay development.
Sensitivity and cross-reactions are the recurrent concerns in the detection of antibodies to
arbovirus infection. ELISAs, Immunofluorescence tests (IFT), multiplex microspheres assays
(MIA) or Rapid Diagnostic Tests (RDT) have been used for the detection of IgG or IgM to var-
ious arbovirus [16,31]. Reported sensitivity and specificity varied greatly (39–100%) by the
assay, the antibody isotype detected, the geographical environment, the time since clinical
symptom onset of the infection [16]. For example, in a study performed in French Guiana in
2019 on a panel of 199 samples, including 90 ZIKV positives [32], the authors evaluated two
commercially available ELISA assays and observed sensitivities of 71% and 79% and
Table 6. Percentages of ape samples reacting simultaneously with different arboviral recombinant proteins.
Number of reactive
samples
ONNV_E2 ZIKV_NS1 DENV1_NS1 DENV2_NS1 DENV3_NS1 DNV4_NS1 USUV_NS1 WNV_NS1 WNV_DIII
CHIKV_E2 37 59.5 18.9 2.7 2.7 2.7 2.7 2.7 8.1 24.3
ONNV_E2 27 23.1 3.8 3.8 3.8 3.8 3.8 11.5 34.6
ZIKV_NS1 23 13.0 13.0 8.7 8.7 4.3 8.7 17.4
DENV1_NS1 3 100 66.7 66.7 33.3 66.7 33.3
DENV2_NS1 7 28.6 57.1 14.3 85.7 14.3
DENV3_NS1 2 100 50.0 100 50.0
DENV4_NS1 5 20.0 80.0 20.0
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specificities of 70% and 62% for IgG detection. In our current work, the level of cross-reaction
varied between 0% and 60%, depending on the antigen (Table 3) and correspond to what was
observed in previous studies [33,34].
Variable prevalence of IgG antibodies to arboviral antigens in monkeys
from Cameroon and DRC
The overall IgG prevalence is<5% for all the six arboviruses tested in both Cameroon and the
DRC. Combining all the DENV serotype NS1 antigens as one target increased IgG prevalence
for some monkey species (Table 2). This strategy could thus be a valuable alternative of screen-
ing, especially if ELISA, not MIA, is to be used. This sero-prevalence to arboviruses in general
is lower than in other published papers. For example, a work by Diallo and colleagues [35]
reported 58.8% (10/17) prevalence of DENV in African Green Monkeys (AGMs) in Senegal
using an ELISA assay for screening. In Zambia 34.4% (33/96) of samples from NHPs were pos-
itive for ZIKV using Plaque Reduction Neutralization Test (PRNT) [36]. Another study inves-
tigated the enzootic cycle of CHIKV in monkeys (C. sabaeus, E. patas, and P. papio) collected
over 3 years in Senegal. They used PRNT and found 72% (479/667) seropositivity for CHIKV,
and 40% of 42 randomly selected samples were also positive for ONNV [37]. Buechler et al
investigated the prevalence of ZIKV exposure in wild baboons and AGMs from South Africa
by ELISA assay and found that 4.9% (2/41) and 16% (4/25) had antibodies against ZIKV,
respectively [38]. Another work, performed on samples collected in diverse African mammals
including mandrills from Gabon, Kading [39] and colleagues used PRNT to evaluate the pres-
ence of antibodies to flaviviruses (DENV-2, WNV, YFV) and alphaviruses (CHIKV, ONNV).
In the set of 25 mandrills tested, the authors found that 80% and 76% presented neutralizing
antibodies to flaviviruses and alphaviruses, respectively. Proportion of neutralizing antibodies
as determined PRNT, at the level of different virus was also high, ranging from 16% for
ONNV to 48% for YFV. However, sample dilutions to reach 80% reduction of plaque forma-
tion are often low (1/10 to 1/100) for most of the antigens tested. In our current work, we used
stringent cut-off calculation methods to determine positivity criteria and the observed preva-
lence could thus underestimate the actual situation in wildlife. The difference in the propor-
tion of positive samples in mandrills from our study and the one reported by Kading and
colleagues [39] in Gabon, could also be due to the location or the detection assay used (Lumi-
nex versus PRNT). While we only detect IgG antibodies, PRNT rely on the reaction of all
immunoglobulin isotypes, including IgM. In other monkey species, we observed high preva-
lence of IgG antibodies to some antigens. For example, 31% (16/51) (Table 2) samples from
blue monkeys, presented antibodies to CHIKV-E2 recombinant protein, 7.3% (3/41) samples
from Allan swamp monkey presented IgG to WNV-DIII proteins. Variability by monkey spe-
cies could be due to the ecology of the monkey species. For example, the blue monkey is an
arboreal species that dwells high in the canopy of contiguous and fragmented lowland and
montane tropical moist forests, riverine and gallery forests and could thus be exposed to differ-
ent mosquito vectors than baboons. At higher level of classification (by biotope, S7 Table and
Fig 2), lower prevalence was observed in terrestrial and semi-terrestrial NHPs species, proba-
bly reflecting the ecology of vectors of studied viruses. However, this can only be ascertained
in conjunction with future entomological investigations. The variability we observed in the
proportion of positive samples by monkey species could also be due to geography, i.e, collec-
tion site, and different ecological environment ranging from forest savannah to tropical rain
forest. Age can also play a role, as can be the case for pets whose low prevalence could be rather
explained by their younger age. Indeed, monkeys kept as pets are generally juveniles whose
mothers have been killed by hunters in the wild. In addition, these pets were mainly living in
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urban areas. On the other hand, the large majority (> 90%) of bushmeat samples are from
adult animals. While one would be expecting significant differences between USUV and WNV
viruses and the other arboviruses because birds instead of NHP, are thought to be the reser-
voirs of USUV and WNV viruses, no differences were observed in the present work.
Low prevalence of IgG antibodies to arboviruses in apes from Cameroon
and the DRC
In apes, the overall IgG prevalence to the different arbovirus antigens we tested in the present
work was generally lower than what was observed for monkeys. A primary possibility to
explain this difference is the biological source of the sample. Hence, samples from monkeys
were plasma or dried blood spots, while ape samples were feces dialysates and IgG concentra-
tion in this latter medium is lower than in plasma. Nevertheless, we showed in our earlier
works on HIV/SIV and Ebola that IgG antibodies to these viruses can be detected in fecal dial-
ysates of apes for SIV [19,23] and of survivors to Ebola virus disease, although at lower sensitiv-
ities [25]. The lower prevalence in apes can also be due to their terrestrial and semi-terrestrial
behavior as observed in monkeys. In apes, we observed two distinct patterns of IgG reactivity
towards arboviral antigens. In one side, in bonobos and chimpanzees, antibodies were mainly
directed against WNV-NS1 antigen, and in gorillas against CHIKV-E2 antigen (Table 5). Sig-
nificant difference for CHIKV IgG prevalence was also observed between chimpanzees and
gorillas’ samples collected on the same site (MB site in Cameroon, 0.88% vs 8.69%, p = 0.039).
This dichotomy could be explained by differential behaviors between the Pan genus and goril-
las. Indeed, while gorillas spend their nights in nests on the ground, common chimpanzees
and bonobos have their nests in the trees. They are thus probably exposed to different mos-
quito vectors. Like for monkeys, seroprevalence of IgG positive samples is also unevenly dis-
tributed in sampling sites and can thus also explain differences in species. For example, most
of WNV-NS1 positive bonobos samples were from LA site. This variability by sampling site
warrants further investigation, especially at the entomological level.
Limitations of the present study
A first limitation of our study is the absence of control panel with a set of well documented
samples for each of the viruses we studied here, e.g. USUV and ONNV. This could have
improved the evaluation of the sensitivity of our assay. A second limitation of this novel assay
is the absence of sylvatic virus antigens. Including these antigens in our Multiplex assay could
have increased the chances to detect antibodies against viruses circulating in wildlife. However,
DENV serotypes for which sylvatic counterparts have been identified (DENV-1,-2, and 4),
amino acids identity in NS1 ranged from 91% to 97% and for the envelope, between 93% and
98% (S8 Table). Thus, based on these sequence identities, it is likely that sylvatic infections
have been detected with our assay. Finally, for some species (e.g: drills and Preuss’s monkey)
the sample size was very limited, making it impossible to estimate prevalence of arboviruses in
these monkey species.
In summary, this is the first study that evaluated on a large scale the presence of antibodies
to arboviruses in NHPs to evaluate their role in sylvatic cycles. We used in this work archived
samples from a diverse set of NHPs from Cameroon and the DRC to investigate the circulation
of different arboviruses in these wild animals. Archived samples have helped to address multi-
ple questions relevant to the field of infectious diseases [37]. Because of the overall low IgG
prevalence observed in our study, we cannot conclude that monkeys are an important wildlife
reservoir for arboviruses to maintain the sylvatic viral cycle, especially given the relative low
numbers of NHPs living in close proximity to humans as compared to birds, bats or rodents
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which are also suspected to play a role in the sylvatic life cycle for some of this viruses. Rather,
NHPs might be intermediate hosts of these pathogens. Additional research is still needed in
the improvement of detection tools and to elucidate the sylvatic reservoirs of arboviruses and
their potential impact on human health.
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